While leprosy might seem like an ancient disease, it is very much a disease of the present in 145 countries: in 2016, there were more than 200.000 new leprosy patients registered globally.

Within the framework of the PEOPLE project, a large, multi-partner clinical trial, four methods of preventive treatment are tested, to stop the disease in the Comoros and Madagascar, which are among the most affected countries. Over 100.000 contacts of leprosy patients participate in this study to identify the best approach to protect them from developing leprosy.

The PEOPLE study is led by ITM, which has a longstanding expertise in disease caused by mycobacteria, such as TB, Buruli ulcer and leprosy. More details can be found in the clinical trial registry: https://clinicaltrials.gov/ct2/show/NCT03662022



This project is part of the EDCTP2 programme supported by the European Union:

Latest events

Annual Meeting with Consortium of PEOPLE in Manila


Annual Meeting with Consortium of PEOPLE in Manila

20th International Leprosy Congress

11/09/2019 - 13/09/2019

The International Leprosy Association (ILA) once again presents its compliments to the Philippines authorities for accepting to host the 20th International Leprosy Congress (20th ILC).

Latest news

Travel Report of ITM’s visit to Damien Foundation on the Comoros

December 2, 2021

Our ITM promotors of the PEOPLE project, Bouke de Jong and Epco Hasker, visited the Comoros islands for follow up of the project, which is now going into its fourth year, together with their colleague Dr. Nimer Ortuno Gutierrez from the Damien Foundation. They discussed preparation of potential follow-up projects, further building on the impactful […]

Number of new cases in contacts of leprosy patients decreases after dose of antibiotic

November 23, 2020

Press release – Institute of Tropical Medicine, Antwerp – 5 November 2020 The number of new cases of leprosy decreases in people exposed to M. leprae, who take a one-off dose of the antibiotic rifampicin, as prophylaxis. This is confirmed by preliminary results of the PEOPLE study, presented at an annual consortium meeting. The PEOPLE […]